Datasea Advances International Commercialization of Acoustic Technology Health Robots
Datasea announced continued progress in the international commercialization of its acoustic technology-enabled head-focused health and wellness care robot business, alongside preparations for the U.S. market launch of its acoustic disinfection product line. Building on previously disclosed developments, Datasea is advancing the commercialization of its wellness care robot solutions across China, broader international markets, and the United States through collaboration with strategic partners. In China, related products and services have been deployed in more than 50 cities across approximately 300 service locations. Internationally, the Company has established market cooperation in multiple Asian markets, including South Korea, Hong Kong SAR, Taiwan region, Singapore, Indonesia, and Malaysia. In the United States, Datasea has initiated early-stage commercial rollout activities, including pilot deployments and customer engagements in Boston, New Jersey, Los Angeles, and Phoenix. These developments reflect the Company's efforts to establish a scalable commercialization pathway for its acoustic technology-enabled wellness solutions across multiple geographic markets. In parallel, Datasea announced that its acoustic disinfection products, including its Smart Air Sterilizer, have completed overseas testing and certification procedures and are now preparing for commercial launch in the United States. As disclosed in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, the Company plans to advance U.S. market sales of these products through Datasea Acoustics, its wholly owned Delaware subsidiary.
Trade with 70% Backtested Accuracy
Analyst Views on DTSS
About DTSS
About the author


- FDA Registration Preparation: Datasea is advancing compliance work for FDA establishment registration and device listing for its acoustic brain-computer interface product, having submitted its DUNS application, marking an important preliminary step in the company's international strategy.
- Technological Integration Advantage: The product integrates four core capabilities: acoustic stimulation, bone-conduction neuromodulation, EEG signal acquisition, and AI health management, focusing on non-invasive acoustic neuromodulation applications with broad potential in neurological health.
- Market Expansion Potential: The company believes that the integration of acoustic intervention and physiological signal monitoring provides a differentiated technical pathway compared to traditional invasive BCI methods, potentially offering advantages in safety, accessibility, and user compliance, supporting future commercialization scalability.
- Strategic Investment Direction: CEO Zhixin Liu stated that Datasea will continue to strengthen its technology barriers, enhance product competitiveness, and create new growth opportunities to address the long-term application potential of acoustic neuromodulation and BCI technologies.
- FDA Registration Preparation: Datasea is advancing compliance work for FDA establishment registration and device listing for its acoustic brain-computer interface product, having submitted its DUNS application, marking an important preliminary step in the company's international strategy that is expected to enhance its competitiveness in global markets.
- Integrated Technology Advantages: The product integrates four core capabilities: acoustic stimulation, bone-conduction neuromodulation, EEG signal acquisition, and AI-assisted health management, focusing on non-invasive applications that may offer advantages in safety and accessibility across brain health management and rehabilitation support.
- Market Potential Assessment: The company believes that acoustic neuromodulation and BCI technologies have long-term application potential, and it aims to create new growth opportunities by strengthening technological barriers and enhancing product competitiveness to further drive international market development.
- Compliance Challenges: While the company has initiated FDA-related procedures, it faces uncertainties regarding review timelines, regulatory requirements, and outcomes, as the DUNS application and registration do not equate to FDA approval for commercial distribution, necessitating ongoing attention to subsequent developments.
- Project Delivery Achievement: Datasea has completed the delivery of three AI multimodal solution projects with a total contract value of RMB 6.9 million (approximately USD 1.01 million), marking significant progress in the company's transition towards high-margin, solution-driven business lines.
- Revenue Recognition Outlook: Following the completion of the contracted services, revenue is expected to be recognized in accordance with applicable accounting standards, which will contribute strongly to the company's financial performance and further enhance customer stickiness.
- Successful Corporate Restructuring: On April 16, 2026, Datasea completed its redomicile merger from Nevada to the British Virgin Islands, becoming the surviving public holding company and continuing to trade on the Nasdaq Capital Market under the symbol
- Project Delivery Impact: Datasea has completed three AI multimodal solution projects with a total contract value of RMB 6.9 million (approximately USD 1.01 million), which is expected to contribute significantly to gross profit and further drive the company's transition towards high-margin, solution-driven business lines.
- Accelerated Strategic Transition: Following the completion of these projects, Datasea anticipates revenue recognition in accordance with applicable accounting standards, reflecting customer recognition of its AI multimodal platform capabilities and validating its ability to deliver scalable solutions across multiple commercial scenarios.
- Successful Corporate Restructuring: On April 16, 2026, Datasea completed its redomicile merger from Nevada to the British Virgin Islands, becoming the surviving public holding company, which enhances the company's potential for international development while continuing to trade on the Nasdaq Capital Market under the symbol “DTSS.”
- Market Expansion Strategy: The company is leveraging its multimodal data processing and intelligent agent collaboration capabilities to expand intelligent, scenario-based digital solutions across small and micro enterprise services, new media marketing, digital rural services, and beauty and wellness digitalization, aiming to improve business quality and operational performance while creating sustainable long-term value for shareholders.
- Market Expansion Plans: Datasea has deployed its wellness care robot solutions in over 50 cities across approximately 300 service locations in China, demonstrating strong growth potential in the domestic market while establishing partnerships in multiple Asian countries for international expansion.
- U.S. Market Strategy: The company’s acoustic disinfection product line has completed overseas testing and certification, with early-stage commercial rollout activities initiated in Boston, New Jersey, Los Angeles, and Phoenix, laying the groundwork for future market entry in the U.S.
- Revenue Expectations: Based on preliminary internal assessments, if current commercialization initiatives progress as planned, the company anticipates generating approximately $10 million in incremental revenue in the next fiscal year, contingent on market adoption and execution progress.
- Technological Innovation and Application: Datasea's acoustic disinfection products, such as the Smart Air Sterilizer, aim to improve air quality in both household and commercial settings, and the adaptability of its acoustic technology across various scenarios may provide a differentiated competitive advantage in the market.
- Revenue Growth Potential: Based on preliminary internal assessments, Datasea anticipates that its newly launched wellness care robots and acoustic disinfection products could contribute approximately $10 million in incremental revenue in the next fiscal year, contingent on market adoption and execution progress.
- International Market Expansion: Datasea's wellness care robot solutions have been deployed in over 300 service locations across more than 50 cities in China, while establishing market cooperation in multiple Asian markets including South Korea, Hong Kong, Taiwan, Singapore, Indonesia, and Malaysia, reflecting positive strides in its international strategy.
- U.S. Market Preparation: The company has initiated early-stage commercial rollout activities in the U.S. across Boston, New Jersey, Los Angeles, and Phoenix, aiming to enhance market acceptance of its acoustic disinfection products through pilot deployments and customer engagements, thereby solidifying its foothold in North America.
- Product Certification Completed: Datasea's acoustic disinfection products, including the Smart Air Sterilizer, have completed overseas testing and certification, and are now preparing for launch in the U.S. market, expected to provide effective air disinfection solutions for both household and commercial environments, enhancing the company's competitiveness in environmental hygiene.








